Prelude Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
|
|||||
|
2025
Q1 | $678K | Buy |
|
|||||
|
2024
Q4 | $456K | Buy |
|
|||||
|
2024
Q3 | $300K | Buy |
|
|||||
|
2024
Q2 | $267K | Buy |
|
|||||
|
2024
Q1 | $230K | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $17K | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $127K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3K | Sell |
|
|||||
|
2019
Q1 | $264K | Buy |
|
|||||
|
2018
Q4 | $210K | Buy |
|
|||||
|
2018
Q3 | $239K | Buy |
|
|||||
|
2018
Q2 | $36K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $686K | Buy |
|
|||||
|
2017
Q3 | $311K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $671K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $506K | Buy |
|
|||||
|
2016
Q1 | $475K | Hold |
|
|||||
|
2015
Q4 | $582K | Sell |
|
|||||
|
2015
Q3 | $566K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $82K | Sell |
|
|||||
|
2014
Q3 | $80K | Sell |
|
|||||
|
2014
Q2 | $83K | Buy |
|